Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology VC Funds in Austria

Last updated: Apr 2024 A list of 50 VC funds that invest in Biotechnology startups based in Austria. We rank investors based on the number of investments they made in Biotechnology companies from Austria. We update this investor list every month.

Top 50 Biotechnology VC Funds in Austria

Investor	Biotechnology Austria investments
xista science ventures	9
tecnet equity	6
aws Fondsmanagement GmbH	5
MIG Capital	5
Arax Capital Partners	3
Longevitytech.fund	2
R42 Group	2
PUSH VC	2
Aescap Venture	2
TSVC	2
aws Gründerfonds (aws Founders Fund)	2
bmp Ventures	2
Nina Capital	2
APEX Ventures	2
red-stars.com	2
Climentum Capital	1
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H	1
Fund F	1
HBM Partners	1
PONTIS Venture Partners Management	1
Credit Agricole CIB	1
Gamma Capital Partners	1
Lansdowne Partners	1
Satgana	1
Air Street Capital	1
HackCapital	1
The Austrian Research Promotion Agency (FFG)	1
Andera Partners	1
EIT Health	1
Tet Ventures	1
Forbion Capital Partners	1
Polaris Partners	1
Novartis Venture Fund	1
42CAP	1
OrbiMed	1
BackBone Ventures	1
FastVentures	1
NovaCapital	1
Amino Collective	1
10x Founders	1
Sofinnova Partners	1
Synthesis Capital	1
IBG Beteiligungsgesellschaft Sachsen-Anhalt	1
FCPG Affi	1
Übermorgen Ventures	1
ICL Planet Startup Hub	1
Borregaard ASA	1
Auxxo	1
4SC	1
Die Wirtschaftskammer	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guideclimate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, SaaS
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
revitalyze — revitalyze is an award-winning greentech platform that enables a circular construction industry through a unique approach to the reuse of building elements.
Lightning Company — The Lightning Company is the first EU-based bitcoin and lightning payment gateway. We want to make bitcoin payments as easy and attractive as possible, ensuring that customers have no additional costs, whilst merchants receive attractive processing fees.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Funding Round, Series B
Germany, Austria, Canada

Portfolio highlights

AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Calyxha Biotechnologies GmbH — A new perspective on inflammation

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Austria

Portfolio highlights

Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
Reservoir Neuroscience — Reservoir Neuroscience is a biopharma company that develops novel therapeutics to repair dysfunctional blood vessels in the brain. Reservoir Neuroscience was founded in 2019 and is based in Emeryville, California.

| Investments that move industries

Investment focus

Software, Apps, Health Care
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
Ohana — Ohana helps you to protect your child in the digital world. Limit screentime, get insights & guidance, block apps & websites and filter inappropriate content.

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Investment focus

Biotechnology, Pharmaceutical, Chemical
Series A, Series B, Funding Round
United Kingdom, Austria, Belgium

Portfolio highlights

Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja JÃ¤Ã¤ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (KrÃ¦ftens BekÃ¦mpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Avantium — Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.
F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

MyShell — MyShell is a decentralized and comprehensive platform for discovering, creating, and staking AI-native apps.
KURUKURU — Bring your comics and visual stories to life in clicks on KURUKURU.
Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
ToolSense — Connecting the way OEMs do business.ToolSense enables OEMs to improve customer service, generate insights for R&D and increase customer loyalty - through digitizing their products with the 'ToolSense NOW' IIoT platform and 'ToolSense IOT' Hardware.ToolSense is the winner of Austrian Foreign Trade Award "Born GlobalChampion 2018", ORF Futurezone Award "Best IoT Startup 2017", part of Deutsche Telekom's "hub:raum NB-IoT Warp Program", part of SAP's "Startup Focus Program" and part of University of Applied Sciences Technikum Vienna's "Student Startup Incubator Program".
Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Neotiv — Enabling cognitive health
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
InLine-Med — Radiologists perform safe, precise & easy interventions with the InLine-Med surgical tools and assistance devices.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Pre-Seed
Germany, Austria, United Kingdom

Portfolio highlights

sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Investment focus

CleanTech, Clean Energy, Biotechnology
Seed, Series A, Series B
Sweden, Spain, Austria

Portfolio highlights

Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
Jolt Electrodes — Home - Manufacturer of activated electrodes for electrolysers - alkaline (AWE), anion exhcnage membrane (AEM), saltwater chlorinator
Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.

Financing for startups in Styria

Investment focus

Software, Audio, Travel
Seed, Grant, Funding Round
Austria

Portfolio highlights

teamazing — ONLINE TEAM EVENTS, BUT AMAZING! We enthuse teams. For better teamwork and more fun at work. This leads to better products, higher profitability and happier employees. teamazing was founded in 2014 as a startup in Graz. The winning team now counts 25 employees in Graz, Vienna and Munich and specialized in online team building during the Coronacrisis. Before that, the company expanded to Germany in 2018 and became the market leader for teambuilding events in Austria in 2019.
Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.

The European Venture Fund that backs gender-diverse founder teams.

Investment focus

EdTech, Software, Mobile Apps
Pre-Seed
Austria

Portfolio highlights

Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
Ada Growth — Deine Mentorin in der Tasche. Gewinne, binde und entfalte die Potenziale der weiblichen Talente in deinem Unternehmen.

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)

Investment focus

Software, Manufacturing, RFID
Series A, Series B, Series C
Austria, Germany

Portfolio highlights

evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.

Investment focus

Energy, Biotechnology, Health Care
Debt Financing, Series A, Series B
France, United Kingdom, United States

Portfolio highlights

ShowYou — They are developing the first digital solution dedicated to real estate developers for the management of acquisition modifying works (TMA). They created the first configurator in interactive plans allowing the customer to study his own modifications under the control of the promoter. With SHOW YOU: - save time - clarify and make the work morereliable - improve the satisfaction of your customers
Credem Banca — Credem Banca provides banking services.
Gunvor Group — Gunvor Group is one of the world’s largest independent commodities trading houses by turnover, creating logistics solutions that safely and efficiently move physical energy from where it is sourced and stored to where it is demanded most. With strategic investments in industrial infrastructure—refineries, pipelines, storage, terminals, mining andupstream—Gunvor further generates sustainable value across the global supply chain for its customers.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.

Investment focus

Mobile, iOS, Mobile Apps
Series A, Seed, Series C
Austria, Switzerland, United States

Portfolio highlights

Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Fundamental Equity Investing, since 1998

Investment focus

Biotechnology, Machine Learning, Finance
Funding Round, Series A, Series C
United Kingdom, United States, Austria

Portfolio highlights

Replay — Reprogramming biology by writing and delivering big DNA
Oxford Ionics — Oxford Ionics is delivering world-leading innovations to create the most powerful, accurate and reliable quantum computers.
Osler Diagnostics — Lab-quality diagnostics for anyone, anywhere, at any time

Satgana is a Climate Tech VC firm on a mission to invest in planet-positive startups building the Future of Earth.

Investment focus

Electronics, B2B, Biotechnology
Pre-Seed, Seed
Kenya, France, Austria

Portfolio highlights

Loewi — Loewi allows you to sell your two-wheeled companion.
Revivo — Revivo is an online marketplace for electronics spare parts, tools & accessories.
Arda Biomaterials — Arda Biomaterials transforms waste feedstocks into smarter, circular biomaterials for fashion, home goods, automotive and more.

Air Street Capital invests in AI-first technology and life science companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, Canada, France

Portfolio highlights

CellVoyant — We provide services to accelerate development of stem cell therapies. We make therapy development faster and more cost-effective.
Lambda Automata — Building the digital backbone for the age of autonomous warfare.
Interloom Technologies — Interloom offers AI-driven process automation for enterprises to maximize organizational efficiency and accuracy.

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Investment focus

Biotechnology, Food and Beverage, Food Processing
Seed, Pre-Seed, Series A
United States, Israel, United Kingdom

Portfolio highlights

PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Investment focus

Software, Health Care, Information Technology
Grant, Seed, Angel
Austria, United States, Belgium

Portfolio highlights

Impact AI — Impact AI is the platform for delivering impactful human-centric AI technology and products.
Kickscale — The AI-powered conversation intelligence platform records, transcribes, and analyzes meetings to provide tailored training recommendations to every sales rep
simplify.art — simplify.art is building a safe admin and communication platform for artists and collectors. It is the first tool with a fully unlimited free basic version. The first service with data sharing between users. And the first to integrate an ecosystem of others working tools (insurance coming summer 2023). In fall 2023 simplify.art will launch a thefirst AI-curated market place that can suggest artworks based on their context and meaning.

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Investment focus

Biotechnology, Health Care, Medical
Series B, Private Equity, Funding Round
France, United States, Germany

Portfolio highlights

MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Investment focus

Health Care, Medical Device, Medical
Grant, Pre-Seed, Seed
United Kingdom, Spain, Ireland

Portfolio highlights

Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.

Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.

Investment focus

Food and Beverage, Biotechnology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, Germany, United Kingdom

Portfolio highlights

Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
RevivBio — RevivBio is a biotechnology company that focuses on microbial innovation. The company was founded in 2021 and is headquartered in Frederick, Maryland.
Chef Robotics — Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
Aiolos Bio — Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by anaccomplished team with decades of drug development experience and leadership in the biotech industry.
Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
United States, Singapore, Ireland

Portfolio highlights

Tausight — Tausight is specifically designed to help Healthcare ensure the confidentiality, integrity, and availability of ePHI.
Triveni Bio — Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.
Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.

42CAP is a seed stage investment firm based in Munich, Germany. They initially invest € 0.5 to 1.5m in seed-stage tech- and data-driven companies across Europe with global ambition.With eCircle they previously built one of Europe’s largest SaaS companies and sold the profitable business to Teradata (NYSE:TDC) in 2012.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Series A, Series B
Germany, France, Sweden

Portfolio highlights

scnd — The marketplace solution to sell services online. Start selling services directly or through a marketplace with third party providers and scale infinitely.
Second — The marketplace solution to sell services online. Start selling services directly or through a marketplace with third party providers and scale infinitely.
Flawless — Use Flawless to real-time monitor your operational data and quickly identify & resolve incidents. Start in just 5 minutes, no coding required.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Tyra Biosciences — Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra is using its proprietary SNÅP platform, which is optimized to enable rapid and precise refinement of structural design through iterative molecular SNÅPshots, in orderto generate next-generation product candidates that are specifically designed to address acquired drug resistance and provide alternative treatment options. Tyra is initially focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR, family, which are altered in approximately 7% of all cancers. Tyra’s lead product candidate, TYRA-300, is designed to selectively inhibit FGFR3, with an initial focus on patients with bladder cancer.
Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Financial Services, Robotics
Seed, Convertible Note, Series A
Switzerland, Germany, Israel

Portfolio highlights

Aepsy — Aepsy is a mental health care located in Zürich,Switzerland and part of the Data Processing, Hosting, and Related Services Industry.
SQUAKE — We help your business to create sustainable products. Made for travel and logistics companies.
Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production

venture capital

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Hungary, South Korea, United States

Portfolio highlights

Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.

Investment focus

Software, SaaS, Semiconductor
Seed, Pre-Seed, Series B
Italy, Austria

Portfolio highlights

xFarm Technologies — The agricultural business is becoming more and more complex due to legal requirements and product certification. On the other hand, technologies evolve and create opportunity. xFarm is a startup that aims at the digitization of agriculture, providing innovative tools that can support farmers and food supply chain's stakeholders in themanagement of their companies. Created by farmers and tailored to the agricultural sector, its main focus is on ease of use, intuitiveness and complete adaptability to agricultural realities. The digital ecosystem includes a free agricultural application, available on both mobile and desktop and integrated with advanced premium modules, a dashboard Analytics dedicated to professionals and a line of IoT sensors selected, optimized and connected by xFarm.
Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
Newarc srl — With the help of technology, we simplify and improve the home buying and selling process.

Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Biomia — Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs in pain, addiction, and depression.
Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
Germany, United States, India

Portfolio highlights

Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
NodeShift — NodeShift is a cloud service provider that enables companies to create and run safe applications on a budget.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

BetterOmics — The Omics AI Cloud
l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

We are The Future Food Investors. Alternative Proteins Pioneers, we combine Smart Capital, Deep Expertise and Food Tech Startups!

Investment focus

Organic Food, Biotechnology, Food Processing
Seed, Series B, Series C
Israel, United States, Austria

Portfolio highlights

Equinom — Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up.Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew27% in 2020 and is projected to reach $162B by 2030.The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of projected demand for plant-based foods.What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogues more delicious, nutritious, cost-effective and sustainable. Ingredients designed by deep tech to bring out nature’s best The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring the quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience that are critical to ensure food security in light of climate change. What makes Equinom a compelling foodtech investment and collaborator? Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.
UPSIDE Foods — Growing real meat directly from animal cells.
Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Investment focus

Electronics, Software, Medical Device
Funding Round, Seed, Series A
Germany, Austria

Portfolio highlights

Wingfield — Wingfield ist dein Zugang zu einem virtuellen Tenniserlebnis.
Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
COMAN Software — COMAN Software provides innovative software for project management in machine and plant construction.

FCPG Affi

Investment focus

Medical, Biotechnology, Pharmaceutical
Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.

We are an early stage VC for climate tech startups.

Investment focus

Energy, Software, Renewable Energy
Seed, Pre-Seed, Funding Round
Germany, Switzerland, Finland

Portfolio highlights

InPlanet — Our vision is to to remove gigatons of CO2 from the atmosphere while regenerating soils in the tropics.
Openvolt — A developer friendly API for unlocking access to smart meter data across Europe. Build more impactful apps in Energy Efficiency, ESG, EV Charging, Demand Response and a host of other use cases.
E-mobilio — E-mobilio is a consulting and mediation platform for electromobility.

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Investment focus

Biotechnology, Agriculture, Organic Food
Seed
Israel, Austria

Portfolio highlights

Lavie bio — Improve food quality, agricultural sustainability and productivity through the introduction of microbiome based ag-biological products.
Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Borregaard operates one of the world's most advanced and sustainable biorefineries.

Investment focus

Biotechnology, Chemical Engineering
Seed
Austria

Portfolio highlights

Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.

The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female (co-)founded startups in Europe.

Investment focus

Software, Apps, Service Industry
Seed, Pre-Seed, Series A
Germany, United Kingdom, France

Portfolio highlights

Filu — Tierversorgung, wann und wie immer du es brauchst. In der Praxis, Zuhause und unterwegs.
FINDIQ — FINDIQ is a young company based in the heart of the Ostwestfalen-Lippe industrial zone. We have developed a novel strategy as a software producer to intelligently integrate knowledge management and help solutions for machine service. FINDIQ develops its service solution with the industry, whether for machine makers, operators, or service providers.
DUDE CHEM — DUDE CHEM is a leading company in green chemical manufacturing based in Berlin.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Investment focus

Health Care, Biotechnology
Seed
Austria

Portfolio highlights

Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.

Investment focus

Software, Music, mHealth
Seed, Pre-Seed, Funding Round
Austria

Portfolio highlights

Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
The Apollinaire Group (TAG) — Intelligent supply chain management company.
SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate